4 months ago
CRBP
AnalystsJeff JonesJeff Jones's Stock Forecasts
AnalystsJeff Jones
Sectors:
Analyst Ranking
Top 7%
#316 out of 4587 analysts
Average Return
+29.19%
Win Rate
44%27 out of 62
Risk vs Reward
Poor
Good
Jeff Jones's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Fusion Pharmaceuticals IncFUSN | +727.31% | $2.60 | $21.51 | 2023-09-28 - 2024-05-17 | Buy |
Corbus Pharmaceuticals Holdings IncCRBP | +631.71% | $6.15 | $45.00 | 2023-08-08 - 2024-05-17 | Buy |
Corbus Pharmaceuticals Holdings IncCRBP | +369.82% | $9.31 | $43.74 | 2023-05-09 - 2024-05-09 | Buy |
Prometheus Biosciences IncRXDX | +235.61% | $59.57 | $199.92 | 2022-10-03 - 2023-06-15 | Buy |
Perspective Therapeutics IncCATX | +229.22% | $0.49 | $1.60 | 2023-05-18 - 2024-05-17 | Buy |
Jeff Jones Analyst Color
Get additional color on Jeff Jones's coverage of popular stocks
Jeff Jones's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Zura Bio LtdZURA | 2 | Buy | $21.00 | +247.11% | Maintains | 10 days ago |
Seres Therapeutics IncMCRB | 3 | Buy | $4.00 | +334.78% | Maintains | 11 days ago |
Corbus Pharmaceuticals Holdings IncCRBP | 5 | Buy | $60.00 | +33.33% | Maintains | 12 days ago |
Corvus Pharmaceuticals IncCRVS | 2 | Buy | $8.00 | +249.34% | Maintains | 14 days ago |
Pliant Therapeutics IncPLRX | 5 | Buy | $48.00 | +214.34% | Reiterates | 14 days ago |
Chemomab Therapeutics LtdCMMB | 4 | Buy | $6.00 | +613.44% | Upgrades | 15 days ago |
Kymera Therapeutics IncKYMR | 2 | Buy | $52.00 | +48.78% | Maintains | 17 days ago |
Perspective Therapeutics IncCATX | 3 | Buy | $1.50 | -6.25% | Reiterates | 2 months ago |
Cellectar Biosciences IncCLRB | 2 | Buy | $12.00 | +263.64% | Reiterates | 2 months ago |
Ventyx Biosciences IncVTYX | 7 | Buy | $12.00 | +153.70% | Upgrades | 2 months ago |
Evolent Health IncEVH | 1 | Buy | $45.00 | +95.06% | Initiates Coverage On | 3 months ago |
Fusion Pharmaceuticals IncFUSN | 3 | Buy | $15.00 | -30.26% | Maintains | 4 months ago |
Cyclacel Pharmaceuticals IncCYCC | 3 | Buy | $120.00 | +5,140.17% | Maintains | a year ago |
Point Biopharma Global IncPNT | 2 | Buy | $13.00 | N/A | Reiterates | a year ago |
Novan IncNOVNQ | 2 | Buy | $8.00 | N/A | Maintains | a year ago |
Pmv Pharmaceuticals IncPMVP | 5 | Buy | $15.00 | N/A | Reiterates | a year ago |
An2 Therapeutics IncANTX | 1 | Buy | $24.00 | N/A | Maintains | a year ago |
Moleculin Biotech IncMBRX | 2 | Buy | $75.00 | N/A | Reiterates | a year ago |
Prometheus Biosciences IncRXDX | 6 | Buy | $150.00 | N/A | Maintains | a year ago |
Evaxion Biotech AEVAX | 2 | Buy | $110.00 | N/A | Maintains | 2 years ago |
Notable Labs LtdNTBL | 1 | Buy | $5.50 | N/A | Assumes | 2 years ago |
Rain Oncology IncRAIN | 1 | Buy | $15.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.